DCM
MRK icon

Deuterium Capital Management’s Merck MRK Stock Holding History

Deuterium Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,238
Closed -$470K – 100
2022
Q4 		$470K Buy
+4,238
New +$433K 1.25% 18
2022
Q3 		– Sell
-3,294
Closed -$300K – 48
2022
Q2 		$300K Hold
3,294
– – 1.02% 24
2022
Q1 		$270K Buy
+3,294
New +$260K 0.35% 51

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deuterium Capital Management's MRK Position: Q1 2023 in Review

Deuterium Capital Management sold out of Merck (MRK) in Q1 2023, closing a stake of 4,238 shares — an estimated $470K sold.

Deuterium Capital Management first reported a position in MRK in Q1 2022 and held it in 3 quarters. The position peaked at $470K in Q4 2022. 3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

  • Deuterium Capital Management reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
  • Deuterium Capital Management sold 4,238 Merck shares in Q1 2023, an estimated $470K.
  • Deuterium Capital Management first reported a position in Merck in Q1 2022 and held it in 3 quarters.
  • Deuterium Capital Management's Merck position peaked at $470K in Q4 2022.
  • 3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on Deuterium Capital Management's 13F filing for Q1 2023, filed 12 May 2023.